Contract awarded for £25M pharmaceutical facility job

An artist's impression of the facility. Image: Doosan Babcock
An artist's impression of the facility. Image: Doosan Babcock

Doosan Babcock has been awarded a £25M contract by healthcare giant GlaxoSmithKline (GSK) to create a new Active Pharmaceutical Ingredients (API) facility at the GSK Montrose site in Angus, Scotland.

The firm will work with GSK to design, build and install the three storey facility. Doosan Babcock will field a team of 40 engineers on the project. The team have completed an initial front end engineering design study in 2014.

 

GSK will recruit 25 employees at the facility once it is complete in summer 2016.

 

Doosan Babcock chief executive officer Andrew Hunt said: “This is a milestone contract for Doosan Babcock and it is great to see that our major investment and ongoing work in Scotland’s pharmaceutical sector is being noticed.

 

“We are proud to be working with GSK on a project that will offer a major boost to the local economy, bring jobs to the region, and ultimately provide essential healthcare products for millions of people.”

 

The API facility will produce active ingredients for three of GSK’s new medicines for the management of respiratory conditions such as asthma and chronic obstructive pulmonary disease.

 

Elsewhere in Scotland Doosan Babcok has made a £6M investment in a new Process Engineering Centre at its Renfrew site, backed by a £1.5M grant from Scottish Enterprise.


This has already seen the creation of 25 skilled jobs and paved the way for the development of an engineering skills ‘centre of excellence’ to support customers in the pharmaceutical and process industries.

Please rate

Comments 

Name
Email
  Ctrl + Enter

Most Read

New Barhale / Doosan JV secures double award

New Barhale / Doosan JV secures double award

The joint venture, which brings together two of the UK’s leading water sector specialist contractors, will undertake infrastructure and non-infrastructure capital projects through the framework including, in the case of Lot 2, civils-led and, under Lot 3, MEICA-led work. Severn Trent, which

Thames Water gets ready to tender £2.6bn AMP7 construction work contracts

Thames Water gets ready to tender £2.6bn AMP7 construction work contracts

Thames' draft AMP7 plan includes a number of complex projects, significant programmes and anticipates a potential increased volume in maintenance activity in response to changing customer and stakeholder needs, population growth and a changing environment. Thames has set out details of the proposed

MWH Treatment wins Severn Trent AMP7 framework contracts

MWH Treatment wins Severn Trent AMP7 framework contracts

We are pleased to hear that our client water sector specialist MWH Treatment has been awarded a place on Severn Trent’s AMP7. The agreement extends an existing 20-year relationship and MWH Treatment (MWHT) will develop and deliver a share of the £2 billion capital works programme,

This website uses cookies to enhance your user experience. By continuing to use this site, you consent to our use of these cookies. See our Cookie Policy.